drugset / Trial / NCT07707375

A Study of LY4268989 (MORF 057) in Healthy Participants

NCT07707375

Phase 1 Not yet recruiting 50 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to identify if two different tablets of LY4268989 (MORF 057) work similarly in healthy participants given different meals. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. There will be 18 inpatient stays at the clinical research unit (CRU). The study will last about 9 weeks.

Timeline

Start
2026-07
Primary completion
2026-10
Completion
2026-10

Drugs

EvaluationDrugModalityDoseRoute
Subject LY4268989 Unknown Oral

Indications

No indication recorded.